Rxo Inc (RXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,469,000 | 1,421,000 | 1,419,000 | 1,433,000 | 1,667,000 |
| Cost of Goods | 1,250,000 | 1,185,000 | 1,165,000 | 1,201,000 | 1,407,000 |
| Gross Profit | 219,000 | 236,000 | 254,000 | 232,000 | 260,000 |
| Operating Expenses | 261,000 | 243,000 | 254,000 | 262,000 | 284,000 |
| Operating Income | -42,000 | -7,000 | N/A | -30,000 | -24,000 |
| Interest Expense | 9,000 | 9,000 | 8,000 | 9,000 | 8,000 |
| Other Income | 0 | 1,000 | -2,000 | 0 | -1,000 |
| Pre-tax Income | -51,000 | -15,000 | -10,000 | -39,000 | -33,000 |
| Income Tax | -5,000 | -1,000 | -1,000 | -8,000 | -8,000 |
| Net Income Continuous | -46,000 | -14,000 | -9,000 | -31,000 | -25,000 |
| Net Income | $-46,000 | $-14,000 | $-9,000 | $-31,000 | $-25,000 |
| EPS Basic Total Ops | -0.28 | -0.08 | -0.05 | -0.18 | -0.17 |
| EPS Basic Continuous Ops | -0.27 | -0.08 | -0.05 | -0.18 | -0.17 |
| EPS Diluted Total Ops | -0.28 | -0.08 | -0.05 | -0.18 | -0.17 |
| EPS Diluted Continuous Ops | -0.27 | -0.08 | -0.05 | -0.18 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.07 | 0.01 | 0.04 | -0.03 | 0.06 |
| EBITDA(a) | $-14,000 | $19,000 | $30,000 | $2,000 | $9,000 |